LD Micro Conference
Companies
COMPANY PROFILE
Simulations Plus
Ticker: slp
Simulations Plus (SLP) develops and produces software for use in pharmaceutical research and education, as well as provides contract research services to the pharmaceutical industry.

Its software products include ADMET Predictor that offers numerical models for predicting absorption, distribution, metabolism, excretion, and toxicity properties of chemical compounds from their molecular structures; MedChem Studio, a tool for medicinal and computational chemists for data mining and designing new drug-like molecules; DDDPlus, a software program that is used by formulation scientists to reduce the number of cut-and-try attempts to design new drug formulations, as well as to design in vitro experiments to mimic in vivo conditions; and GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals. The company also provides contract research and consulting services in the areas oral absorption and pharmacokinetics.

In addition, it develops and sells interactive, educational software programs that simulate science experiments conducted in middle school, high school, and junior college science classes, as well as provides Abbreviate, a productivity software program.

Further, the company designs and develops computer software and manufactures augmentative communication devices and computer access products for physically disabled persons. It markets augmentative and alternative communication products to speech pathologists, occupational therapists, rehabilitation engineers, special education teachers, disabled persons, and relatives of disabled persons, through a network of employee representatives, independent dealers, and resellers.

The company operates in North America, South America, Europe, Asia, and Oceania.

Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.

Information provided by Capital IQ.
COMPANY WEBSITE
PRESENTATION
December 8th, 3:00 pm - Track Three